Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2013

View Archived Issues

Novartis prepares new protein kinase inhibitors

Initial results available from phase I/II study of indibulin in metastatic breast cancer

Iron chelator ameliorates experimental Alzheimer's disease

French scientists design novel DCL enzyme inhibitors

Merck & Co. presents new mGlu2 receptor agonists

U.S. scientists divulge novel cytochrome P450 1A2 inducers

Metabolex presents new GPBA receptor agonists

Novel compounds for autoimmune disorders patented

Ultragenyx inlicenses triheptanoin from Baylor Research Institute

BIKAM Pharmaceuticals prepares new opsin-2 ligands

Esperion's ETC-1002 lowers LDL cholesterol in phase II trial

GeoVax completes enrollment in phase I/II trial for HIV/AIDS vaccine

Dosing completed in phase III BromSite study

Phase II trial of NeoFuse stem cell product meets endpoints

Novel drug-eluting bioadhesive gel reduces inflammation in atherosclerotic plaques in vivo

Morphotek discloses results from phase III study in platinum-sensitive epithelial ovarian cancer

KaloBios begins phase II study of Humaneered PEGylated monoclonal antibody fragment

Topline data reported from phase II study of tivantinib in colorectal cancer

MSD suspends availability of Tredaptive

Evotec advances compound into preclinical development under collaboration with Ono

Mirabegron approved in Europe

European Commission approves use of Zytiga earlier in the treatment cycle

Biota synthesizes promising inhibitor of cell division protein FtsZ

FDA grants orphan drug designation to Telik's investigational treatment for MDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...